Andreas Gross - global product manager of Inspection Technology at Syntegon Technology, explains how artificial intelligence (AI) is being used to ensure pharmaceutical products are safe.
AI
Whether in automated driving, computer games or face recognition – artificial intelligence (AI) is transforming our everyday lives. The required software and algorithms are already used in many domains, including visual inspection of manufactured components. So why not apply them to an area where safety plays a crucial role: the production and inspection of drugs for human use.
One of the main challenges in introducing AI consists in transferring applications to complex processes and developing suitable implementation and validation concepts for the strictly regulated pharmaceutical industry. Inspection is a very challenging process. This is especially true for products with difficult characteristics, such as highly viscous parenteral solutions. Those cases usually require long development and optimisation times for vision algorithms before achieving a balanced operational level of detection and false reject rates. AI has the potential of shortening this development period and optimising the desired results more quickly.